IP Library Granted Patent US 11,466,281
Granted Patent B2
US 11,466,281 · App. 16/110,954 · Granted Oct 11, 2022

Generation of water-soluble cannabinoid compounds in yeast and plant cell suspension cultures and compositions of matter

Inventors: Richard T. Sayre (Los Alamos, NM); Elton Carvalho Gonçalves (Los Alamos, NM); Tawanda Zidenga (White Rock, NM)
Assignee: TRAIT BIOSCIENCES INC.
C12N15/81C12N1/185C12N5/10C12N9/0042C12N9/1048C12P1/02C12P7/42C12P17/06C12R2001/865C12Y106/02004C12Y204/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,466,281
App. No.
16/110,954
Granted
Oct 11, 2022
Kind
B2
Abstract

The present invention includes systems, methods and compositions for the generation of water-soluble cannabinoids in yeast, and other plant cell suspension cultures as well as novel water-soluble cannabinoid compounds. The present invention also includes compositions of matter that may contain one or more water-soluble cannabinoids.

Claims (7)

1. An in vivo method for the generation of water-soluble cannabinoids in a yeast cell suspension culture comprising the steps:

(a) genetically modified a yeast cell to express a heterologous nucleotide sequence encoding at least one heterologous glycosyltransferase, operably linked to a promotor, wherein said at least one heterologous glycosyltransferase exhibits activity towards one or more cannabinoids and wherein said nucleotide sequence encoding said at least one heterologous glycosyltransferase is selected from the group consisting of: SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31, SEQ ID NO. 57, and SEQ ID NO. 59;

(b) establishing a suspension cell culture of said genetically modified yeast cells;

(c) introducing said one or more cannabinoids to said suspension cell culture of genetically modified yeast cells; and

(d) isolating one or more glycosylated cannabinoids from said suspension cell culture.

2. The method of claim 1 , wherein said genetically modified yeast cell comprise genetically modified yeast cells selected from the group consisting of: genetically modified Pichia pastoris cells, genetically modified Saccharomyces cerevisiae cells, and genetically modified Kluyveromyces marxianus cells.

3. The method of claim 1 , wherein said nucleotide sequence encoding the heterologous glycosyltransferase comprises SEQ ID NO. 57 or SEQ ID NO. 59.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2021
From: GOTHAM GREEN ADMIN 1, LLC
To: TRAIT BIOSCIENCES INC., TRAIT NM INC., TRAIT BIOSCIENCES (CANADA) INC., AND TWIGG PHARMA LTD.
Reel/Frame 055705/0452 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2020
From: CARVALHO GONÇALVES, ELTON, DR.
To: TRAIT BIOSCEINCES, INC.
Reel/Frame 054626/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2020
From: ZIDENGA, TAWANDA, DR.
To: TRAIT BIOSCEINCES, INC.
Reel/Frame 054626/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2020
From: SAYRE, RICHARD T., DR.
To: TRAIT BIOSCEINCES, INC.
Reel/Frame 054623/0738 →
SECURITY INTEREST Recorded Jun 26, 2020
From: TRAIT BIOSCIENCES INC.; TRAIT NM INC.; TRAIT BIOSCIENCES (CANADA) INC.; TWIGG PHARMA LTD.
To: GOTHAM GREEN ADMIN 1, LLC
Reel/Frame 053057/0852 →
Continuity (6)
Continuation In Part PCTUS2018041710 · Jul 11, 2018
Continuation In Part PCTUS2018024409 · Mar 26, 2018
Provisional Application 62621166 · Jan 24, 2018
Provisional Application 62588662 · Nov 20, 2017
Provisional Application 62531123 · Jul 11, 2017
Related Publication 20190078168A1 · Mar 14, 2019